A 2018 Reference Guide to the Banff Classification of Renal... : Transplantation A 2018
Reference Guide to the Banff Classification of Renal Allograft Pathology : Transplantation Log …

Abstract 2021 marks the 30th anniversary of the original development of the Banff
Classification of Kidney Allograft Pathology, when in August 1991 a group of pathologists …

The kidney sessions of the 2017 Banff Conference focused on 2 areas: clinical implications
of inflammation in areas of interstitial fibrosis and tubular atrophy (i‐IFTA) and its relationship …

The XIII Banff meeting, held in conjunction the Canadian Society of Transplantation in
Vancouver, Canada, reviewed the clinical impact of updates of C4d-negative antibody …

For three decades, the international Banff classification has been the gold standard for
kidney allograft rejection diagnosis, but this system has become complex over time with the …

Detection of mismatched human leukocyte antigens by adaptive immune cells is considered
as the main cause of transplant rejection, leading to either T-cell mediated rejection or …

Background Donor-specific antibodies create an immunologic barrier to transplantation.
Current therapies to modify donor-specific antibodies are limited and ineffective in the most …

Background Late antibody-mediated rejection (ABMR) is a leading cause of transplant
failure. Blocking IL-6 has been proposed as a promising therapeutic strategy. Methods We …

Antibody-mediated rejection (AMR) is a recognized cause of allograft dysfunction in lung
transplant recipients. Unlike AMR in other solid-organ transplant recipients, there are no …

Extending the functional integrity of renal allografts is the primary goal of transplant
medicine. The development of donor-specific antibodies (DSAs) posttransplantation leads to …